Organogenesis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Organogenesis and other ETFs, options, and stocks.

About ORGO

Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA. 

CEO
Gary S. Gillheeney
CEOGary S. Gillheeney
Employees
854
Employees854
Headquarters
Canton, Massachusetts
HeadquartersCanton, Massachusetts
Founded
1985
Founded1985
Employees
854
Employees854

ORGO Key Statistics

Market cap
227.75M
Market cap227.75M
Price-Earnings ratio
-2.11
Price-Earnings ratio-2.11
Dividend yield
Dividend yield
Average volume
1.27M
Average volume1.27M
High today
$1.77
High today$1.77
Low today
$1.72
Low today$1.72
Open price
$1.76
Open price$1.76
Volume
151.47K
Volume151.47K
52 Week high
$7.08
52 Week high$7.08
52 Week low
$1.54
52 Week low$1.54

Stock Snapshot

Organogenesis(ORGO) stock is priced at $1.77, giving the company a market capitalization of 227.75M. It carries a P/E multiple of -2.11.

As of 2026-08-14, Organogenesis(ORGO) stock has fluctuated between $1.72 and $1.77. The current price stands at $1.77, placing the stock +2.9% above today's low and 0.0% off the high.

Organogenesis(ORGO) shares are trading with a volume of 151.47K, against a daily average of 1.27M.

In the last year, Organogenesis(ORGO) shares hit a 52-week high of $7.08 and a 52-week low of $1.54.

In the last year, Organogenesis(ORGO) shares hit a 52-week high of $7.08 and a 52-week low of $1.54.

ORGO News

The Motley Fool 16h
Organogenesis Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Organogenesis Holdings President, Chief Executive Officer, and Chair of...

Organogenesis Q2 2026 Earnings Call Transcript
Simply Wall St 5d
Organogenesis Holdings After Earnings Cut, Guidance Reset And $75 Million Raise, Still A Bargain?

Advertisement What the latest earnings mean for Organogenesis Holdings stock Organogenesis Holdings (ORGO) is back in focus after second quarter results showe...

Organogenesis Holdings After Earnings Cut, Guidance Reset And $75 Million Raise, Still A Bargain?

People also own

Based on the portfolios of people who own ORGO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.